Satoh T, Saionji K
Department of Clinical Pathology, Juntendo University School of Medicine, Tokyo.
Rinsho Byori. 1999 Apr;47(4):359-64.
This study was carried out on 52 hemodialysis (HD) patients. The concentrations of macrophage colony-stimulating factor (M-CSF) in plasma and dialysate were measured by ELISA. Plasma M-CSF level increased in HD patients. M-CSF levels of dialysate were under the detection limit. The monocyte subpopulations were studied using double staining of CD14 and CD16 by flow cytometry. The percentage and absolute number of CD14+/CD16+ cells were much higher in HD patients (p < 0.001, respectively, Mann-Whitney U-test). A new subpopulation of blood monocyte, CD14+/CD16+, has been identified which possesses the features of tissue macrophage. The elevations of this subpopulation were also reported under some pathological conditions, and in subject treated with recombinant M-CSF. HD is the pathological condition which induces the increase in plasma M-CSF as well as change of monocyte subpopulation.
本研究对52例血液透析(HD)患者进行。采用酶联免疫吸附测定法(ELISA)检测血浆和透析液中巨噬细胞集落刺激因子(M-CSF)的浓度。HD患者血浆M-CSF水平升高。透析液中M-CSF水平低于检测限。采用流式细胞术对CD14和CD16进行双重染色研究单核细胞亚群。HD患者中CD14+/CD16+细胞的百分比和绝对数量要高得多(分别为p < 0.001,曼-惠特尼U检验)。已鉴定出血液单核细胞的一个新亚群CD14+/CD16+,其具有组织巨噬细胞的特征。在一些病理状况下以及接受重组M-CSF治疗的受试者中也报告了该亚群的升高。HD是导致血浆M-CSF升高以及单核细胞亚群变化的病理状况。